Copyright
©The Author(s) 1999.
World J Gastroenterol. Feb 15, 1999; 5(1): 57-60
Published online Feb 15, 1999. doi: 10.3748/wjg.v5.i1.57
Published online Feb 15, 1999. doi: 10.3748/wjg.v5.i1.57
Table 4 Pharmacolinetical parameters of 125I sodium alginate-BSA NP in rats
| Parameter | Unit | Value |
| A | Bq | 3022 × 102 |
| α | 1/h | 0.07 |
| B | Bq | 3.03 × 103 |
| β | 1/h | -0.11 |
| Ka | 1/h | 1.46 |
| V/F | Bq | 1428 × 103 |
| T1/2α | h | 9.42 |
| T1/2β | h | -6.07 |
| T1/2Ka | h | 0.47 |
| K21 | 1/h | -0.11 |
| K10 | 1/h | 0.07 |
| K12 | 1/h | -0.00035 |
| AUC | Bq × h | 3.9 × 109 |
| CL(s) | Bq × h/Bq | 105 × 103 |
| T(peak) | h | 2.18 |
| Cmax | Bq | 2.45 × 107 |
- Citation: Yi YM, Yang TY, Pan WM. Preparation and distribution of 5-fluorouracil 125I sodium alginate-bovine serum albumin nanoparticles. World J Gastroenterol 1999; 5(1): 57-60
- URL: https://www.wjgnet.com/1007-9327/full/v5/i1/57.htm
- DOI: https://dx.doi.org/10.3748/wjg.v5.i1.57